| scholarly article | Q13442814 |
| P2093 | author name string | Krutika K Sawant | |
| Sandip S Chavhan | |||
| Shamsunder S Dodiya | |||
| Aruna G Korde | |||
| P2860 | cites work | Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection | Q41107174 |
| Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation | Q41990284 | ||
| Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. | Q42108498 | ||
| Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs | Q45162715 | ||
| Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles | Q46818077 | ||
| Intestinal uptake and biodistribution of novel polymeric micelles after oral administration | Q46930065 | ||
| Body distribution of camptothecin solid lipid nanoparticles after oral administration | Q48197933 | ||
| Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles | Q48211150 | ||
| Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding. | Q52429372 | ||
| Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase | Q28325776 | ||
| Rational design of peptide-based HIV proteinase inhibitors | Q28330897 | ||
| Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. | Q33933351 | ||
| Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. | Q33935309 | ||
| Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration | Q33988624 | ||
| Modeling and comparison of dissolution profiles | Q34215811 | ||
| Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies | Q35579403 | ||
| Nanosuspensions: a promising drug delivery strategy. | Q35826447 | ||
| Practical aspects of transporter model systems: a case study involving SQV. | Q35828049 | ||
| Recent advances and patents on solid lipid nanoparticles | Q37347857 | ||
| Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. | Q39750666 | ||
| P433 | issue | 6 | |
| P921 | main subject | saquinavir | Q422654 |
| nanoparticle | Q61231 | ||
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 515-527 | |
| P577 | publication date | 2011-07-05 | |
| P1433 | published in | Journal of Microencapsulation | Q15708887 |
| P1476 | title | Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies | |
| P478 | volume | 28 |
| Q51074380 | Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal. |
| Q30407466 | Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability |
| Q54530036 | Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation. |
| Q53769446 | Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability. |
| Q38970984 | Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model |
| Q59793444 | Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles |
| Q39243464 | In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy |
| Q48374696 | Investigations on pharmacokinetics and biodistribution of polymeric and solid lipid nanoparticulate systems of atypical antipsychotic drug: effect of material used and surface modification |
| Q38104343 | Nanocrystals for the parenteral delivery of poorly water-soluble drugs |
| Q45235236 | Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine |
| Q37141404 | Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs |
| Q38132471 | Recent advancements in mechanical reduction methods: particulate systems |
Search more.